(Q45714370)

English

Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site.

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

carcinoma of unknown primary

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Stéphane Culine

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Michel Fabbro

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Gilles Romieu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Didier Cupissol

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Frédéric Pinguet

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

94

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

840-846

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Treatment of patients with cancer of an unknown primary site

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Cancer of unknown primary site

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Treatment of the patient with adenocarcinoma of unknown origin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10264

21 January 2018

Identifiers

10.1002/CNCR.10264

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

release_gcsyx5snwrcv3mpk3wlppnd5am

1 reference

https://api.fatcat.wiki/v0/release/gcsyx5snwrcv3mpk3wlppnd5am

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11857320%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45714370&oldid=1844653257"